Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ronchi

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
JAMA Oncology|July 12, 2019
Value of Molecular Classification for Prognostic Assessment of Adrenocortical CarcinomaGuillaume Assié, Anne Jouinot, Martin Fassnacht, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, James F H Pittaway, Barbara Altieri, et al.
Cancer Communications (London, England)|March 4, 2025
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, James F H Pittaway, Barbara Altieri, et al.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
JAMA Oncology|July 12, 2019
Value of Molecular Classification for Prognostic Assessment of Adrenocortical CarcinomaGuillaume Assié, Anne Jouinot, Martin Fassnacht, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, James F H Pittaway, Barbara Altieri, et al.
Cancer Communications (London, England)|March 4, 2025
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, James F H Pittaway, Barbara Altieri, et al.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Pageof 19